Kezar Life Sciences, Inc. - ROE
KZR
Price:
$7.29
Market Cap:
$53.86M
Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant unmet medical needs in both immune-mediated diseases and various forms of cancer. The company's most advanced experimental drug is KZR-616, a specialized immunoproteasome inhibitor. This candidate is currently undergoing Phase 2 clinical evaluation for several conditions, including lupus nephritis, dermatomyositis, and polymyositis. Concurrently, KZR-616 is also in Phase 1b clinical trials for systemic lupus erythematosus and lupus nephritis. In its preclinical pipeline, Kezar is developing KZR-2...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
KZR
PE Ratio
[-1.18]
ROE
[-58.35%]
Current Ratio
[24.46]
Dividend Yield
[0%]
Enterprise Value
[-11018667.00]
Dividend History
The ROE as of June 2026 (TTM) for Kezar Life Sciences, Inc. (KZR) is -58.35%
According to Kezar Life Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -58.35%. This represents a change of 302.13% compared to the average of -14.51% of the last 4 quarters.
Kezar Life Sciences, Inc. (KZR) Historical ROE (quarterly & annually)
How has KZR ROE performed in the past?
The mean historical ROE of Kezar Life Sciences, Inc. over the last ten years is -27.00%. The current -58.35% ROE has changed 116.08% with respect to the historical average. Over the past ten years (40 quarters), KZR's ROE was at its highest in in the December 2017 quarter at 8.95%. The ROE was at its lowest in in the March 2017 quarter at -21.00%.
Average
-27.00%
Median
-28.68%
Minimum
-79.96%
Maximum
51.58%
Kezar Life Sciences, Inc. (KZR) ROE by Quarter and Year
Discovering the peaks and valleys of Kezar Life Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 114.79%
Maximum Annual ROE = 51.58%
Minimum Annual Increase = -164.22%
Minimum Annual ROE = -79.96%
| Year | ROE | Change |
|---|---|---|
| 2025 | -79.96% | 11.65% |
| 2024 | -71.62% | 31.87% |
| 2023 | -54.31% | 114.79% |
| 2022 | -25.29% | -8.88% |
| 2021 | -27.75% | -6.28% |
| 2020 | -29.61% | -34.14% |
| 2019 | -44.96% | 111.13% |
| 2018 | -21.29% | -164.22% |
| 2017 | 33.16% | -35.72% |
Kezar Life Sciences, Inc. (KZR) Average ROE
How has KZR ROE performed in the past?
The current ROE of Kezar Life Sciences, Inc. (KZR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-68.63%
5-year avg
-51.79%
10-year avg
-27.00%
Kezar Life Sciences, Inc. (KZR) ROE vs. Peers
How is KZR’s ROE compared to its peers?
Kezar Life Sciences, Inc.’s ROE is greater than Tempest Therapeutics, Inc. (-729.89%), greater than FibroGen, Inc. (-234.28%), greater than OnKure Therapeutics, Inc. (-61.02%), greater than Aligos Therapeutics, Inc. (-139.47%), less than Mersana Therapeutics, Inc. (183.15%), greater than Barinthus Biotherapeutics plc (-63.87%), greater than PDS Biotechnology Corporation (-346.03%), greater than X4 Pharmaceuticals, Inc. (-94.90%), greater than Xilio Therapeutics, Inc. (-117.24%), greater than Actinium Pharmaceuticals, Inc. (-218.67%),
| Company | ROE | Market cap |
|---|---|---|
| -729.89% | $5.46M | |
| -234.28% | $36.69M | |
| -61.02% | $61.26M | |
| -139.47% | $32.67M | |
| 183.15% | $145.36M | |
| -63.87% | $27.05M | |
| -346.03% | $53.30M | |
| -94.90% | $398.03M | |
| -117.24% | $57.80M | |
| -218.67% | $32.32M |
Build a custom stock screener for Kezar Life Sciences, Inc. (KZR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kezar Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kezar Life Sciences, Inc. (KZR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kezar Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kezar Life Sciences, Inc.'s ROE?
How is the ROE calculated for Kezar Life Sciences, Inc. (KZR)?
What is the highest ROE for Kezar Life Sciences, Inc. (KZR)?
What is the 3-year average ROE for Kezar Life Sciences, Inc. (KZR)?
What is the 5-year average ROE for Kezar Life Sciences, Inc. (KZR)?
How does the current ROE for Kezar Life Sciences, Inc. (KZR) compare to its historical average?